{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:09:26Z","timestamp":1790492966942,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Medicine Technological Innovation Team of Shanxi Province","award":["2020TD19"],"award-info":[{"award-number":["2020TD19"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-024-01127-1","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:02:16Z","timestamp":1725321736000},"page":"1663-1678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transcription repression of estrogen receptor alpha by ghrelin\/Gq\/11\/YAP signaling in granulosa cells promotes polycystic ovary syndrome"],"prefix":"10.1007","volume":"37","author":[{"given":"Pengfei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"issue":"9588","key":"1127_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. The Lancet. 2007;370(9588):685\u201397.","journal-title":"The Lancet"},{"issue":"4","key":"1127_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","volume":"13","author":"R Deswal","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261.","journal-title":"J Hum Reprod Sci"},{"key":"1127_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.657889","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Li J, Yan Z, Liu D, Ma J, Tong N. Improvement of insulin sensitivity increases pregnancy rate in infertile PCOS women: a systemic review. Front Endocrinol. 2021;12: 657889.","journal-title":"Front Endocrinol"},{"issue":"4","key":"1127_CR4","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/jcm12041454","volume":"12","author":"S Singh","year":"2023","unstructured":"Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12(4):1454.","journal-title":"J Clin Med"},{"issue":"1","key":"1127_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tjog.2021.11.009","volume":"61","author":"R Rashid","year":"2022","unstructured":"Rashid R, Mir SA, Kareem O, Ali T, Ara R, Malik A, et al. Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. Taiwan J Obstet Gynecol. 2022;61(1):40\u201350.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1127_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1385138","author":"Y Akalu","year":"2020","unstructured":"Akalu Y, Molla MD, Dessie G, Ayelign B. Physiological effect of ghrelin on body systems. Int J Endocrinol. 2020. https:\/\/doi.org\/10.1155\/2020\/1385138.","journal-title":"Int J Endocrinol"},{"issue":"5","key":"1127_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/09513590.2018.1534096","volume":"35","author":"DP Baldani","year":"2019","unstructured":"Baldani DP, Skrgatic L, Kasum M, Zlopasa G, Kralik Oguic S, Herman M. Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality. Gynecol Endocrinol. 2019;35(5):401\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"1127_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105750","volume":"204","author":"D Pan","year":"2020","unstructured":"Pan D, Wang K, Cao G, Fan K, Liu H, Li P, et al. Inhibitory effect of central ghrelin on steroid synthesis affecting reproductive health in female mice. J Steroid Biochem Mol Biol. 2020;204: 105750.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"12","key":"1127_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ncpendmet1003","volume":"4","author":"M Tena-Sempere","year":"2008","unstructured":"Tena-Sempere M. Ghrelin as a pleotrophic modulator of gonadal function and reproduction. Nat Clin Pract Endocrinol Metab. 2008;4(12):666\u201374.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"19","key":"1127_CR10","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.3390\/nu14194191","volume":"14","author":"Z-T Jiao","year":"2022","unstructured":"Jiao Z-T, Luo Q. Molecular mechanisms and health benefits of ghrelin: a narrative review. Nutrients. 2022;14(19):4191.","journal-title":"Nutrients"},{"issue":"16","key":"1127_CR11","doi-asserted-by":"publisher","first-page":"9196","DOI":"10.3390\/ijms23169196","volume":"23","author":"J Feng","year":"2022","unstructured":"Feng J, Qiu S, Zhou S, Tan Y, Bai Y, Cao H, et al. mTOR: A potential new target in nonalcoholic fatty liver disease. Int J Mol Sci. 2022;23(16):9196.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1127_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13048-023-01305-z","volume":"17","author":"Z Huang","year":"2023","unstructured":"Huang Z, Xu T, Wu H, Weng L, Cai J, Ge H, et al. Correlation between ovarian follicular development and Hippo pathway in polycystic ovary syndrome. J Ovar Res. 2023;17(1):14.","journal-title":"J Ovar Res"},{"issue":"2","key":"1127_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/cells10020459","volume":"10","author":"X-L Xu","year":"2021","unstructured":"Xu X-L, Deng S-L, Lian Z-X, Yu K. Estrogen receptors in polycystic ovary syndrome. Cells. 2021;10(2):459.","journal-title":"Cells"},{"key":"1127_CR14","doi-asserted-by":"publisher","unstructured":"Marie C, Pierre A, Mayeur A, Giton F, Grynberg M, Cohen-Tannoudji J et al. Dysfunction of estrogen signaling as a novel molecular signature of polycystic ovary syndrome. Endocrine abstracts; Bioscientifica 2023: https:\/\/doi.org\/10.1530\/endoabs.90.P451","DOI":"10.1530\/endoabs.90.P451"},{"issue":"1","key":"1127_CR15","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1038\/s41467-022-30831-5","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Zhuo S, Zhuang T, Cho YS, Wu G, Liu Y, et al. YAP inhibits ER\u03b1 and ER+ breast cancer growth by disrupting a TEAD-ER\u03b1 signaling axis. Nat Commun. 2022;13(1):3075.","journal-title":"Nat Commun"},{"issue":"3","key":"1127_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1210\/jc.2005-2153","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R. Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006;91(3):781\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1127_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4149\/gpb_2019059","volume":"39","author":"J Huang","year":"2020","unstructured":"Huang J, Zeng F, Xu Q, Ma J. Cryptotanshinone decreases granulosa cell apoptosis and restores ovarian function in mice with premature ovarian failure. Gen Physiol Biophys. 2020;39(3):277.","journal-title":"Gen Physiol Biophys"},{"issue":"4","key":"1127_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s13770-021-00424-2","volume":"19","author":"MH Dong","year":"2022","unstructured":"Dong MH, Kim YY, Ku S-Y. Identification of stem cell-like cells in the ovary. Tissue Eng Regener Med. 2022;19(4):675\u201385.","journal-title":"Tissue Eng Regener Med"},{"issue":"3","key":"1127_CR19","first-page":"1855","volume":"19","author":"Y Liu","year":"2020","unstructured":"Liu Y, Ma X, Chen X, Chen J, Yuan L, Li L, et al. Expression of SUMO associated proteins in the mouse endometrium is regulated by ovarian hormones throughout the estrous cycle. Exp Ther Med. 2020;19(3):1855\u201363.","journal-title":"Exp Ther Med"},{"issue":"6","key":"1127_CR20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1210\/endrev\/bnac013","volume":"43","author":"KL Clark","year":"2022","unstructured":"Clark KL, George JW, Przygrodzka E, Plewes MR, Hua G, Wang C, et al. Hippo signaling in the ovary: emerging roles in development, fertility, and disease. Endocr Rev. 2022;43(6):1074\u201396.","journal-title":"Endocr Rev"},{"key":"1127_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10815-019-01628-1","volume":"37","author":"R Masciangelo","year":"2020","unstructured":"Masciangelo R, Hossay C, Chiti MC, Manavella DD, Amorim CA, Donnez J, et al. Role of the PI3K and Hippo pathways in follicle activation after grafting of human ovarian tissue. J Assist Reprod Genet. 2020;37:101\u20138.","journal-title":"J Assist Reprod Genet"},{"key":"1127_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111808","volume":"559","author":"T Mizutani","year":"2023","unstructured":"Mizutani T, Orisaka M, Kawabe S, Morichika R, Uesaka M, Yoshida Y. YAP\/TAZ-TEAD is a novel transcriptional regulator of genes encoding steroidogenic enzymes in rat granulosa cells and KGN cells. Mol Cell Endocrinol. 2023;559: 111808.","journal-title":"Mol Cell Endocrinol"},{"key":"1127_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.904754","volume":"13","author":"A Smith","year":"2022","unstructured":"Smith A, Woodside B, Abizaid A. Ghrelin and the control of energy balance in females. Front Endocrinol. 2022;13: 904754.","journal-title":"Front Endocrinol"},{"key":"1127_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9782373","author":"Q Xie","year":"2019","unstructured":"Xie Q, Xiong X, Xiao N, He K, Chen M, Peng J, et al. Mesenchymal stem cells alleviate DHEA-induced polycystic ovary syndrome (PCOS) by inhibiting inflammation in mice. Stem Cells Int. 2019. https:\/\/doi.org\/10.1155\/2019\/9782373.","journal-title":"Stem Cells Int"},{"key":"1127_CR25","doi-asserted-by":"crossref","unstructured":"Sander V, Luchetti CG, Solano MaE, Elia E, Di Girolamo G, Gonzalez C et al. Role of the N, N\u2032-dimethylbiguanide metformin in the treatment of female prepuberal BALB\/c mice hyperandrogenized with dehydroepiandrosterone. Reproduction. 2006;131(3):591\u2013602.","DOI":"10.1530\/rep.1.00941"},{"key":"1127_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102345","volume":"68","author":"KA Glendining","year":"2023","unstructured":"Glendining KA, Campbell RE. Recent advances in emerging PCOS therapies. Curr Opin Pharmacol. 2023;68: 102345.","journal-title":"Curr Opin Pharmacol"},{"key":"1127_CR27","doi-asserted-by":"publisher","first-page":"110958","DOI":"10.1016\/j.biopha.2020.110958","volume":"133","author":"L Wang","year":"2021","unstructured":"Wang L, Zhou J, Gober H-J, Leung WT, Huang Z, Pan X, et al. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype. Biomed Pharmacother. 2021;133:110958.","journal-title":"Biomed Pharmacother"},{"key":"1127_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3389\/fendo.2018.00815","volume":"9","author":"L Sominsky","year":"2019","unstructured":"Sominsky L, Goularte JF, Andrews ZB, Spencer SJ. Acylated ghrelin supports the ovarian transcriptome and follicles in the mouse: implications for fertility. Front Endocrinol. 2019;9:815.","journal-title":"Front Endocrinol"},{"issue":"9","key":"1127_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13077","volume":"34","author":"MT Ringuet","year":"2022","unstructured":"Ringuet MT, Furness JB, Furness SGB. G protein-coupled receptor interactions and modification of signalling involving the ghrelin receptor, GHSR1a. J Neuroendocrinol. 2022;34(9): e13077.","journal-title":"J Neuroendocrinol"},{"key":"1127_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2015.00014","author":"D Kamato","year":"2015","unstructured":"Kamato D, Thach L, Bernard R, Chan V, Zheng W, Kaur H, et al. Structure, function, pharmacology, and therapeutic potential of the G protein, G\u03b1\/q, 11. Front Cardiovasc Med. 2015. https:\/\/doi.org\/10.3389\/fcvm.2015.00014.","journal-title":"Front Cardiovasc Med."},{"issue":"8","key":"1127_CR31","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/cr.2015.88","volume":"25","author":"R Gong","year":"2015","unstructured":"Gong R, Hong AW, Plouffe SW, Zhao B, Liu G, Yu F-X, et al. Opposing roles of conventional and novel PKC isoforms in Hippo-YAP pathway regulation. Cell Res. 2015;25(8):985\u20138.","journal-title":"Cell Res"},{"issue":"4","key":"1127_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.molmed.2015.01.003","volume":"21","author":"SW Plouffe","year":"2015","unstructured":"Plouffe SW, Hong AW, Guan K-L. Disease implications of the Hippo\/YAP pathway. Trends Mol Med. 2015;21(4):212\u201322.","journal-title":"Trends Mol Med"},{"issue":"1","key":"1127_CR33","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1038\/s41467-018-04620-y","volume":"9","author":"F Yao","year":"2018","unstructured":"Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton BN, et al. SKP2-and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nat Commun. 2018;9(1):2269.","journal-title":"Nat Commun"},{"key":"1127_CR34","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1007\/s00018-019-03412-x","volume":"77","author":"E You","year":"2020","unstructured":"You E, Ko P, Jeong J, Keum S, Kim J-W, Seo Y-J, et al. Dynein-mediated nuclear translocation of yes-associated protein through microtubule acetylation controls fibroblast activation. Cell Mol Life Sci. 2020;77:4143\u201361.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1127_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0014-5793(01)03288-4","volume":"513","author":"MB Yaffe","year":"2002","unstructured":"Yaffe MB. How do 14-3-3 proteins work?\u2013Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 2002;513(1):53\u20137.","journal-title":"FEBS Lett"},{"issue":"11","key":"1127_CR36","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41419-021-04338-8","volume":"12","author":"Y Lin","year":"2021","unstructured":"Lin Y, Li C, Xiong W, Fan L, Pan H, Li Y. ARSD, a novel ER\u03b1 downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo\/YAP pathway. Cell Death Dis. 2021;12(11):1042.","journal-title":"Cell Death Dis"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-024-01127-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T09:11:55Z","timestamp":1728465115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-024-01127-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["1127"],"URL":"https:\/\/doi.org\/10.1007\/s13577-024-01127-1","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"assertion":[{"value":"4 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial or proprietary interests in any of the materials discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Appropriate informed consent was obtained from all patients. The Institutional Review Board of the Children\u2019s Hospital of Shanxi and the Women\u2019s Health Center reviewed and approved all procedures (IRB-KYSB-2023-017). All experimental protocols followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Animal Care and Use Committee of the Children\u2019s Hospital of Shanxi and Women Health Center reviewed and approved all procedures (IRB-KYSB-2023-017).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}